SQUAMOUS CELL CARCINOMA, HEAD AND NECK
Clinical trials for SQUAMOUS CELL CARCINOMA, HEAD AND NECK explained in plain language.
Never miss a new study
Get alerted when new SQUAMOUS CELL CARCINOMA, HEAD AND NECK trials appear
Sign up with your email to follow new studies for SQUAMOUS CELL CARCINOMA, HEAD AND NECK, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Old drug gets new look as last hope for tough head & neck cancers
Disease control CompletedThis study tested whether an older chemotherapy drug called mitomycin C could help control advanced head and neck cancer that had grown despite all standard treatments. It involved 48 adults whose cancer had spread or returned and was no longer responding to common therapies. The…
Matched conditions: SQUAMOUS CELL CARCINOMA, HEAD AND NECK
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Drug trial aims to stop Cancer's return after surgery
Disease control CompletedThis study tested whether adding the immunotherapy drug pembrolizumab (MK-3475) to standard surgery could better control advanced head and neck cancer. It involved 67 high-risk patients with stage III or IV cancer that could be surgically removed. Researchers aimed to see if the …
Matched conditions: SQUAMOUS CELL CARCINOMA, HEAD AND NECK
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC